Abstract
Activated cell-mediated immunity is known to be accompanied by elevated concentrations of 7,8-dihydroneopterin which in high concentrations was found to interfere with the oxidant-antioxidant balance. In this study we investigated whether 7,8-dihydroneopterin mediates apoptosis of Jurkat T-lymphocytes via a CrmA- or Bcl-2-sensitive pathway. Transient transfection assays with CrmA and Bcl-2 expression constructs showed that apoptosis was not affected by CrmA whereas it was significantly decreased upon cotransfection with Bcl-2 constructs. Results suggest that 7,8-dihydroneopterin-induced apoptosis of T-lymphocytes is mediated by a Bcl-2-sensitive pathway.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Antioxidants / pharmacology
-
Apoptosis / drug effects*
-
Enzyme Activation
-
Enzyme Inhibitors / pharmacology
-
Humans
-
Jurkat Cells
-
Mitogen-Activated Protein Kinases / metabolism
-
Neopterin / analogs & derivatives
-
Proto-Oncogene Proteins c-bcl-2 / genetics
-
Proto-Oncogene Proteins c-bcl-2 / metabolism*
-
Pteridines / pharmacology*
-
Serpins / genetics
-
Serpins / metabolism
-
Signal Transduction / physiology*
-
Staurosporine / pharmacology
-
Viral Proteins*
Substances
-
Antioxidants
-
Enzyme Inhibitors
-
Proto-Oncogene Proteins c-bcl-2
-
Pteridines
-
Serpins
-
Viral Proteins
-
7,8-dihydroneopterin
-
Neopterin
-
interleukin-1beta-converting enzyme inhibitor
-
Mitogen-Activated Protein Kinases
-
Staurosporine